Imaging as an End Point in Ischemia Trials. - Wikidata - awgldk - TriplyDB

Imaging as an End Point in Ischemia Trials.

Imaging as an End Point in Ischemia Trials.

http://www.wikidata.org/entity/Q37863002

about

Imaging as an End Point in Ischemia Trials.

http://www.wikidata.org/entity/Q37863002

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 January 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Imaging as an End Point in Ischemia Trials.

@en

Imaging as an End Point in Ischemia Trials.

@nl

type

label

Imaging as an End Point in Ischemia Trials.

@en

Imaging as an End Point in Ischemia Trials.

@nl

prefLabel

Imaging as an End Point in Ischemia Trials.

@en

Imaging as an End Point in Ischemia Trials.

@nl

P1433

Q37863002-FD3C1105-8E65-40AC-BB8A-EDE8A8B7F35A

P1476

Q37863002-2B8061EB-076B-4265-B325-F0FDEFD8FB04

P2093

Q37863002-46D5EC54-9935-4528-B6D7-B607AE11A73E

Q37863002-F92879B1-8067-434E-BC33-56ACB11A9E45

P2860

Q37863002-08B742DF-3B65-473A-BF2B-119E37972327

Q37863002-11B86829-6957-4C79-BD33-C5620788AE6E

Q37863002-14A3A44A-85E6-4564-B957-EF79CEA86799

Q37863002-1A491CC2-28E3-4660-8BCF-ECE5E0201F36

Q37863002-217DE7C3-4B68-4D22-9CCE-30BA8D407080

Q37863002-23576C0A-6216-43F2-902E-D42FCFD5397E

Q37863002-3262214B-1C39-44DA-8630-D715FC5E2D48

Q37863002-3AD55F55-1625-42DD-93A1-A0E97540778E

Q37863002-3D97A4A9-7AE2-46E2-B321-91953DAB273A

Q37863002-3EAA5D47-949C-4DE6-9275-27F25659D963

P2888

Q37863002-60C0DEB1-F754-436E-BB0A-7514A9FBFDF0

P304

Q37863002-643AFF6E-02F9-42CC-946D-E8B1C4714B6C

P31

Q37863002-484F6BD1-CC12-4FEA-A4F2-C2E2049F91FF

P356

Q37863002-DAD92922-4FA5-4053-B763-80BE0C4C34D2

P433

Q37863002-91DAE310-5FD2-4CF3-B1A5-176EB8C4410A

P478

Q37863002-E563EAF9-0BDC-4A12-BD85-1A9F4FD3802E

P577

Q37863002-432D3F90-9CD8-4F25-9250-CACD595E3C8A

P5875

Q37863002-62E8353E-33DB-4B55-A182-6E1AEDB01797

P698

Q37863002-9C60545E-CA39-4718-954F-4B58AD5E1782

P932

Q37863002-77BA1437-9F9E-4D62-B1D6-E7C17850CA66

P356

S12410-011-9068-6

P1433

Current cardiovascular imaging reports

P1476

Imaging as an End Point in Ischemia Trials.

@en

P2093

Andrew G Howarth

http://www.w3.org/2001/XMLSchema#string

Matthias G Friedrich

http://www.w3.org/2001/XMLSchema#string

P2860

Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?

Inflammation and atherosclerosis

Prognostic value of adenosine stress cardiovascular magnetic resonance in patients with low-risk chest pain

Quantification of regional myocardial oxygenation by magnetic resonance imaging: validation with positron emission tomography

Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease

Oxygenation-sensitive CMR for assessing vasodilator-induced changes of myocardial oxygenation.

BOLD cardiovascular magnetic resonance at 3.0 tesla in myocardial ischemia.

Estimation of perfusion and arterial transit time in myocardium using free-breathing myocardial arterial spin labeling with navigator-echo.

High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis.

Optimal medical therapy with or without PCI for stable coronary disease.

P2888

s12410-011-9068-6

P304

90-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12410-011-9068-6

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51034570

http://www.w3.org/2001/XMLSchema#string

P698

21475396

http://www.w3.org/2001/XMLSchema#string

P932

3047679

http://www.w3.org/2001/XMLSchema#string